BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 14628984)

  • 1. Treatment of previously undiagnosed psychiatric disorders in persons with developmental disabilities decreased or eliminated self-injurious behavior.
    Tsiouris JA; Cohen IL; Patti PJ; Korosh WM
    J Clin Psychiatry; 2003 Sep; 64(9):1081-90. PubMed ID: 14628984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-injurious skin picking: clinical characteristics and comorbidity.
    Wilhelm S; Keuthen NJ; Deckersbach T; Engelhard IM; Forker AE; Baer L; O'Sullivan RL; Jenike MA
    J Clin Psychiatry; 1999 Jul; 60(7):454-9. PubMed ID: 10453800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevalence of psychiatric disorders in French general practice using the patient health questionnaire: comparison with GP case-recognition and psychotropic medication prescription].
    Norton J; de Roquefeuil G; David M; Boulenger JP; Ritchie K; Mann A
    Encephale; 2009 Dec; 35(6):560-9. PubMed ID: 20004287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DSM-IV intermittent explosive disorder: a report of 27 cases.
    McElroy SL; Soutullo CA; Beckman DA; Taylor P; Keck PE
    J Clin Psychiatry; 1998 Apr; 59(4):203-10; quiz 211. PubMed ID: 9590677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychotropic medication use in people with developmental disabilities.
    Curtis JL
    Md Med J; 1997 Oct; 46(9):481-5. PubMed ID: 9327650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olanzapine for self-injurious, aggressive, and disruptive behaviors in intellectually disabled adults: a retrospective, open-label, naturalistic trial.
    Janowsky DS; Barnhill LJ; Davis JM
    J Clin Psychiatry; 2003 Oct; 64(10):1258-65. PubMed ID: 14658977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychotropic prescribing for persons with intellectual disabilities and other psychiatric disorders.
    Edelsohn GA; Schuster JM; Castelnovo K; Terhorst L; Parthasarathy M
    Psychiatr Serv; 2014 Feb; 65(2):201-7. PubMed ID: 24233105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demographic and Clinical Characteristics, Including Subsyndromal Symptoms Across Bipolar-Spectrum Disorders in Adolescents.
    Salazar de Pablo G; Guinart D; Cornblatt BA; Auther AM; Carrión RE; Carbon M; Jiménez-Fernández S; Vernal DL; Walitza S; Gerstenberg M; Saba R; Lo Cascio N; Brandizzi M; Arango C; Moreno C; Van Meter A; Correll CU
    J Child Adolesc Psychopharmacol; 2020 May; 30(4):222-234. PubMed ID: 32083495
    [No Abstract]   [Full Text] [Related]  

  • 9. Association of aggressive behaviours with psychiatric disorders, age, sex and degree of intellectual disability: a large-scale survey.
    Tsiouris JA; Kim SY; Brown WT; Cohen IL
    J Intellect Disabil Res; 2011 Jul; 55(7):636-49. PubMed ID: 21492292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of self-inflicted burn injury in patients with Major Psychiatric Illness.
    Atwell K; Bartley C; Cairns B; Charles A
    Burns; 2019 May; 45(3):615-620. PubMed ID: 30429073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender differences in psychiatric diagnoses among inpatients with and without intellectual disabilities.
    Lunsky Y; Bradley EA; Gracey CD; Durbin J; Koegl C
    Am J Intellect Dev Disabil; 2009 Jan; 114(1):52-60. PubMed ID: 19143463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychiatric consultation in severe and profound mental retardation.
    King BH; DeAntonio C; McCracken JT; Forness SR; Ackerland V
    Am J Psychiatry; 1994 Dec; 151(12):1802-8. PubMed ID: 7977889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical effects and adverse reactions of off-label use of aripiprazole in children and adolescents with developmental disabilities.
    Valicenti-McDermott MR; Demb H
    J Child Adolesc Psychopharmacol; 2006 Oct; 16(5):549-60. PubMed ID: 17069544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of 34 adults with psychogenic excoriation.
    Arnold LM; McElroy SL; Mutasim DF; Dwight MM; Lamerson CL; Morris EM
    J Clin Psychiatry; 1998 Oct; 59(10):509-14. PubMed ID: 9818631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical differences among patients treated for mental health problems in general medical and specialty mental health settings in the National Comorbidity Survey Replication.
    Uebelacker LA; Wang PS; Berglund P; Kessler RC
    Gen Hosp Psychiatry; 2006; 28(5):387-95. PubMed ID: 16950373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comorbid personality disorder and treatment use in a community sample of youths: a 20-year follow-up.
    Kasen S; Cohen P; Skodol AE; First MB; Johnson JG; Brook JS; Oldham JM
    Acta Psychiatr Scand; 2007 Jan; 115(1):56-65. PubMed ID: 17201867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and correlates of DSM-5 bipolar and related disorders and hyperthymic personality in the community.
    Fassassi S; Vandeleur C; Aubry JM; Castelao E; Preisig M
    J Affect Disord; 2014; 167():198-205. PubMed ID: 24995887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and characteristics of undiagnosed bipolar disorders in patients with a major depressive episode: the BRIDGE study.
    Angst J; Azorin JM; Bowden CL; Perugi G; Vieta E; Gamma A; Young AH;
    Arch Gen Psychiatry; 2011 Aug; 68(8):791-8. PubMed ID: 21810644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Problem behavior and psychiatric impairment within a developmentally disabled population. III: Psychotropic medication.
    Jacobson JW
    Res Dev Disabil; 1988; 9(1):23-38. PubMed ID: 3353539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mood and anxiety symptoms in an adolescent with Pervasive Developmental Disorder Not Otherwise Specified and moderate mental retardation.
    Williams DT; Hirsch S; Coffey B
    J Child Adolesc Psychopharmacol; 2007 Oct; 17(5):721-6. PubMed ID: 17979592
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.